| Company | Op. income (TTM) | Sector | Industry | Country | Exchange |
|---|---|---|---|---|---|
| 1 | $2.20B | Healthcare | Diagnostics & Research | United States | NYSE |
| 2 | $1.78B | Healthcare | Diagnostics & Research | United States | Nasdaq |
| 3 | $1.46B | Healthcare | Diagnostics & Research | United States | Nasdaq |
U.S.-exchange common stocks; ADRs and funds excluded. 3 companies. Reported USD values. TTM means trailing twelve months; companies without a comparable value are excluded.